Durable efficacy with fixed-duration BTKi and venetoclax for CLL. Nierengarten MB. Cancer 2024;130:3237.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nierengarten MB. Durable efficacy with fixed-duration BTKi and venetoclax for CLL. Cancer 2024;130:3237.
PMID: 39226085